Myeloid Cell Signaling Identified as Key Driver of Immunotherapy Resistance in Kidney Cancer
In a groundbreaking revelation poised to redefine therapeutic strategies for advanced renal cell carcinoma (RCC), researchers at Dana-Farber Cancer Institute ...
